Lawsuit Settlement News Reports Zimmer NexGen Knee News Update on Lawsuits Against Zimmer Inc.

LOS ANGELES, Oct. 16, 2014 /PRNewswire/ -- MT Services LLC, a Lawsuit Settlement News Reporting Company which operates, announced today a primary focus on assisting plaintiffs who have suffered with complications from Zimmer NexGen Knee implants. A significant amount of lawsuits have been filed against the leading manufacturer of knee implants, Zimmer Inc., over certain models and components of its NexGen medical devices. These components include LPS-Flex, Gender Solutions Female LPS-Flex (GSF-LPS Flex), Cruciate Retaining-Flex Femoral Components (CR-Flex), and CR-Flex Gender Solutions Female CR-Flex (GSF-Flex). The devices were meant to increase range of motion and imitate natural knee function, but plaintiffs who have filed cases against Zimmer Inc. claim that the devices actually caused a decreased range of motion as well as extreme pain, tissue and/or nerve damage, bone degradation or fractures, instability, infection, blood clots, and ultimate failure of device implant. Among those who have filed lawsuits, painful revision surgery was often required.


According to court documents, an estimated 150,000 patients have been implanted with the NexGen Flex devices, and over 1,000 Zimmer Knee lawsuits are currently pending across the country; however, MTS expects these numbers to rise as more knee implants begin to fail. Starting in 2010, the FDA issued recalls for various components of the NexGen knee mechanisms (the NexGen LPS femoral component, the NexGen LPS Flex gender femoral component, and the NexGen MIS tibial components), however, none of the models have been permanently removed from the marketplace. An estimated 50K knee replacements are believed to be directly affected by the recalls. Federal lawsuits have been consolidated into multidistrict litigation (MDL) in the U.S. District Court in the North District of Illinois, with the first bellwether trial set to begin in 2015.

Chris Janish, CEO of MTS, commented on the lawsuits filed, "The Zimmer knee litigation is now beginning to gain a lot of traction with over 1,000 cases filed in courts throughout the U.S. We believe there is a large number of patients who received these implants that are subject to FDA recall, and that they may now beginning to see the debilitating effects of the NexGen product. The time to file a lawsuit claim is now if patients have not done so already."

MTS advises any patients who have suffered complications or dealt with limited mobility from a Zimmer NexGen Knee implant to seek a free legal consultation immediately from a Zimmer Knee Lawyer or Zimmer Knee Law firm or by inquiring directly with MTS at:

MT Services LLC provides up-to-date lawsuit news on Zimmer Knee litigations, as well as various services to assist victims with getting the help they need during this difficult time. These services include: Lawsuit Pre-Settlement Funding Cash Advances, corrective or revision surgery procedure funding (or cash needs related to your surgery), and assistance with obtaining an attorney from a nationally recognized Actos law firm. (Lawsuit funding or surgical funding products should not be considered to be a lawsuit loan, lawsuit loans, settlement loans, pre-settlement loans, or lawsuit settlement loans.)

To learn more about the lawsuit help services that MTS can provide involving the Zimmer Knee litigation visit:

If you or a loved one have been injured by a Zimmer NexGen Knee implant and need lawsuit help, including finding a Zimmer Knee law firm, obtaining up to $30K in pre-settlement lawsuit funding, or obtaining surgical funding, call right now to speak to a live agent at 877.571.0405. You may also fill out a quick application online at: and an agent will contact you shortly.

MT Services LLC is not a law firm and cannot provide legal advice on your case; however, MTS works with lawyers involved in mass tort litigations who are willing to provide a free legal consultation at the consumer's request. For a list of full disclosures please visit the company's website disclosure page at:

Chris Janish, CEO

Ph. 877.571.0405